Status: Recruiting
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.
Participants needed: 1,650
Trial details
Phase: Phase 3Age: 2-3Biological sex: AllType: InterventionalSponsor: Changchun BCHT Biotechnology Co.Updated: Aug 8, 2025Locations: 1
Eligibility criteria
Healthy infants and young children who are permanent residents aged 2 months (60... [+2]
History of pertussis, diphtheria, or tetanus; [+18]